Coping mechanisms to drug stock-outs among patients seeking mental healthcare at outpatient department in Butabika National Referral Mental Hospital, Uganda: A cross-sectional study
Angela Apio, Grifine Agarukamu, Gloria Nicole Amuron, Silas Ojuka, Mike Mugisha, Kalidi Rajab

TL;DR
This study explores how patients at a Ugandan mental health hospital cope with drug shortages and the negative outcomes they face.
Contribution
The study identifies common coping mechanisms and their consequences in a mental healthcare setting with frequent drug stock-outs.
Findings
Only 42.60% of participants had their prescriptions fully filled.
Common coping mechanisms included out-of-pocket drug purchases and skipping doses.
Undesirable outcomes included symptom worsening and relapse.
Abstract
Mental disorders are responsible for a significant proportion of global health burden especially in developing countries. In sub-Saharan Africa optimum care for mental health patients is constrained by frequent drug stock-outs. Patients who are victims of drug stock-outs are compelled to seek coping mechanisms to this challenge. These coping mechanisms may either be adaptive or maladaptive. Consequently, persons living with mental illnesses are prone to experiencing undesirable outcomes. This study purposed to explore coping mechanisms to drug stock-outs among patients seeking care at an outpatient department (OPD) of a national mental healthcare facility in Kampala, Uganda. This was an observational cross-sectional study. A sample size of 385 was obtained by systematic random sampling. Data was collected using a checklist and a questionnaire. The data was analyzed using SPSS version…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Economics and Policy · Mental Health Treatment and Access · Pharmaceutical Practices and Patient Outcomes
